About HyperBranch Medical
HyperBranch Medical is a Healthcare company based in Durham (United States) founded in 2003, and was acquired by Stryker in October 2018. Biosurgical devices are developed using proprietary polymers and hydrogels. HyperBranch Medical has raised $18.69 million across 9 funding rounds from investors including Stryker, The Aurora Funds and H.I.G. Capital. Its focus areas include Life Sciences, Wound Care, Medical Devices and Therapeutic Devices. Its competitors include Adhezion Biomedical, BRIJ Medical and Mussel Polymers; 3 of its 3 listed competitors have raised funding.
Company details
HyperBranch Medical is focused on biosurgical devices based on its proprietary polymers and cross-linked hydrogels. Initial focus is on the surgical sealant market. Lead product is the Adherus AutoSpray Dural Sealant, used to provide closure during surgical procedures. Licensed its liquid ocular bandage technology to Becton Dickinson in 2009. Approved by FDA in Mar 2015 and received CE Mark in 2012.
- Headquarters Durham, United States
- Stage Acquired
- SectorsHealthcare
- Website hyperbranch.com
- Social LinkedIn
- Acquired by Stryker (Oct 2018)
Funding Insights of HyperBranch Medical
HyperBranch Medical has successfully raised a total of $18.69M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $2 million completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18.69M
- Total Rounds 9
- Last Round Series A — $2M
- First Round $6M
(Jan 2005)
- Investors Count 2
All 9 funding rounds of HyperBranch Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2013 | $2M | Series A | – | – | – |
| May 2013 | $500,000 | Series A | – | – | – |
| May 2012 | $1.94M | Series A | – | – | – |
| Oct 2011 | $1.04M | Series A | – | – | – |
| Nov 2010 | $2.07M | Series A | – | – | – |
| Apr 2010 | $2.1M | Series A | – | – | – |
| Apr 2009 | $1.17M | Series A | – | – | – |
| Feb 2009 | $1.87M | Series A | – | – | – |
| Jan 2005 | $6M | Series A | – | The Aurora Funds |
3 investors in total: 3 institutional.
Investors in HyperBranch Medical
HyperBranch Medical has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker, The Aurora Funds and H.I.G. Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| aurorafunds.com | ||||
Private equity capital is invested in small and mid-sized businesses. | higcapital.com | Miami, United States | ||
3D-printed orthopedic products are manufactured for medical applications. | 1941 | stryker.com | Kalamazoo, United States |
Investor details for HyperBranch Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of HyperBranch Medical
4 dated milestones of HyperBranch Medical across 15 years, from founding to its latest funding, stage changes and deals.
- Founded HyperBranch Medical is founded.
- Funding First funding round of $6.0M.
- Funding Latest funding round, Series A, of $2.0M.
- Exit Acquired by Stryker.
Competitors of HyperBranch Medical
HyperBranch Medical has 3 listed competitors in our database, 3 of them funded. They include Adhezion Biomedical, BRIJ Medical and Mussel Polymers.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| adhezion.com | 2001 | Wyomissing, United States | $10.14M | 39 | Developer of cyanoacrylate based surgical, wound management, and infection prevention products | |
| brijmedical.com | 2016 | Marietta, United States | $6.78M | Medical devices for post-surgical and trauma incision care are provided. | ||
| musselpolymers.com | 2019 | Bethlehem, United States | $500,000 | Adhesive solutions are manufactured for diverse materials and applications. |
Detailed competitors of HyperBranch Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of HyperBranch Medical
Websites that share an audience with HyperBranch Medical (hyperbranch.com).
Websites whose visitors overlap most with HyperBranch Medical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
kellow.com | kellow.com | 100% | #9,767,838 | – |
Top companies in Wound Care
3 companies that operate in the same segment as HyperBranch Medical (Wound Care) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | 35 | ||
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | USD 418.63 M | 837 | ||
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hyperbranch Medical
Complete news archive for HyperBranch Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HyperBranch Medical
HyperBranch Medical was founded in 2003 and raised its 1st funding round 2 years after it was founded.
HyperBranch Medical is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
HyperBranch Medical is a funded company, having raised a total of $18.69M across 9 funding rounds to date. The company's 1st funding round was a Series A of $6M, raised on Jan 2005.
HyperBranch Medical is focused on biosurgical devices based on its proprietary polymers and cross-linked hydrogels. Initial focus is on the surgical sealant market. Lead product is the Adherus AutoSpray Dural Sealant, used to provide closure during surgical procedures. Licensed its liquid ocular bandage technology to Becton Dickinson in 2009. Approved by FDA in Mar 2015 and received CE Mark in 2012.
HyperBranch Medical's top competitors include Adhezion Biomedical, BRIJ Medical and Mussel Polymers.
HyperBranch Medical has 3 investors. Key investors include Stryker, The Aurora Funds, and H.I.G. Capital.
Yes. HyperBranch Medical was acquired by Stryker in October 2018.